EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications.

MLA

Li, Boheng, and Wee-Joo Chng. “EZH2 Abnormalities in Lymphoid Malignancies: Underlying Mechanisms and Therapeutic Implications.” Journal of Hematology & Oncology, vol. 12, no. 1, Nov. 2019, p. 118. EBSCOhost, https://doi.org/10.1186/s13045-019-0814-6.

APA

Li, B., & Chng, W.-J. (2019). EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications. Journal of Hematology & Oncology, 12(1), 118. https://doi.org/10.1186/s13045-019-0814-6

Chicago

Li, Boheng, and Wee-Joo Chng. 2019. “EZH2 Abnormalities in Lymphoid Malignancies: Underlying Mechanisms and Therapeutic Implications.” Journal of Hematology & Oncology 12 (1): 118. doi:10.1186/s13045-019-0814-6.